It's been months since the first vaccines proven to protect against SARS-CoV-2 were approved, and their introduction couldn't come soon enough. New options will likely follow, but these early entrants to the market have already changed the public health battle against COVID-19.
The availability of multiple vaccines has renewed hopes that far more lives can be saved, and life itself will gradually return to normal. For organizations taking extraordinary measures to protect employees, customers and other stakeholders while minimizing the effects of disrupted operations, business interests now look brighter.
